Summary

The Global Legionella Testing Market, valued at approximately USD 0.34 billion in 2024, is poised to expand at an impressive CAGR of around 8.20% over the forecast period of 2025-2035. Legionella testing has emerged as an indispensable safeguard in public health and environmental monitoring, serving as the frontline defense in identifying and mitigating outbreaks of Legionnaires’ disease. This bacterial infection, often linked to contaminated water systems, can have severe public health consequences, prompting governments, healthcare providers, and industries to intensify preventive measures. The surging adoption of advanced diagnostic techniques, the tightening of regulatory standards for water safety, and heightened awareness about disease outbreaks are converging to create a fertile growth environment for this market. Furthermore, the rapid pace of urbanization and infrastructural development—often involving complex water systems—has amplified the need for regular Legionella monitoring to protect public safety and comply with international guidelines.
As waterborne disease prevention becomes a top priority, demand for rapid, accurate, and cost-efficient testing methodologies is accelerating. Hospitals, diagnostic laboratories, and water treatment facilities are increasingly investing in PCR-based testing and urinary antigen tests to obtain timely, actionable results. According to data from public health agencies, incidences of Legionnaires’ disease have been climbing in recent years, driven by climate-related factors and aging water infrastructure. The heightened focus on point-of-care diagnostics, coupled with technological breakthroughs in pathogen detection, is expected to further propel market expansion. However, the market must navigate certain restraints, including high testing costs in resource-limited settings and the shift toward alternative disinfection methods that could reduce testing frequency.
From a geographical perspective, North America currently dominates the global Legionella Testing Market, buoyed by its stringent water safety regulations, advanced healthcare infrastructure, and strong adoption of molecular diagnostics. The region’s proactive approach to outbreak prevention, especially in healthcare facilities and public infrastructure, ensures a steady demand for testing services and kits. Meanwhile, Europe remains a formidable player, supported by rigorous EU directives on water quality management and the presence of established testing laboratories. The Asia Pacific region, however, is projected to witness the fastest growth during the forecast period, driven by surging urban populations, industrial expansion, and increased governmental investment in public health systems in countries like China and India. Latin America and the Middle East & Africa are also recognizing the economic and health benefits of early detection, with growing adoption of portable and on-site testing technologies in high-risk environments.
Major market player included in this report are:
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• Qiagen N.V.
• Eurofins Scientific SE
• IDEXX Laboratories, Inc.
• Danaher Corporation
• Pall Corporation
• LuminUltra Technologies Ltd.
• Pro-Lab Diagnostics, Inc.
• Aquacert Ltd.
• ALS Limited
• SUEZ Water Technologies & Solutions
• Merck KGaA
Global Legionella Testing Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Test Type:
• Culture
• Urinary Antigen Test
• DFA
• PCR
By Application:
• Water Testing
• IVD Testing (Urine, Blood)
By End User:
• Hospitals
• Clinics
• Diagnostic Labs
• Water Treatment Industries
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of contents
Chapter 1. Global Legionella Testing Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
  1.2.1. Forecast Model
  1.2.2. Desk Research
  1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
  1.4.1. Market Definition
  1.4.2. Market Segmentation
1.5. Research Assumption
  1.5.1. Inclusion & Exclusion
  1.5.2. Limitations
  1.5.3. Years Considered for the Study

Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis in the Legionella Testing Industry
2.4. Key Findings and Market Snapshot

Chapter 3. Global Legionella Testing Market Forces Analysis
3.1. Market Forces Shaping The Global Legionella Testing Market (2024–2035)
3.2. Drivers
  3.2.1. Rising incidences of Legionnaires’ disease globally
  3.2.2. Stricter government regulations and water safety standards
  3.2.3. Growing adoption of advanced diagnostic methods (PCR, Urinary Antigen Test)
3.3. Restraints
  3.3.1. High cost of testing technologies in resource-limited settings
  3.3.2. Shift toward alternative water disinfection methods reducing testing demand
3.4. Opportunities
  3.4.1. Technological advancements enabling faster and more accurate on-site testing
  3.4.2. Rising infrastructure and urbanization projects with complex water systems

Chapter 4. Global Legionella Testing Industry Analysis
4.1. Porter’s 5 Forces Model
  4.1.1. Bargaining Power of Buyer
  4.1.2. Bargaining Power of Supplier
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
  4.3.1. Political
  4.3.2. Economical
  4.3.3. Social
  4.3.4. Technological
  4.3.5. Environmental
  4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Legionella Testing Market Size & Forecasts by Test Type 2025–2035
5.1. Market Overview
5.2. Global Legionella Testing Market Performance – Potential Analysis (2025)
5.3. Culture Method
  5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  5.3.2. Market size analysis, by region, 2025–2035
5.4. Urinary Antigen Test
  5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  5.4.2. Market size analysis, by region, 2025–2035
5.5. Direct Fluorescent Antibody (DFA)
  5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  5.5.2. Market size analysis, by region, 2025–2035
5.6. Polymerase Chain Reaction (PCR)
  5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  5.6.2. Market size analysis, by region, 2025–2035

Chapter 6. Global Legionella Testing Market Size & Forecasts by Application 2025–2035
6.1. Market Overview
6.2. Global Legionella Testing Market Performance – Potential Analysis (2025)
6.3. Water Testing
  6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  6.3.2. Market size analysis, by region, 2025–2035
6.4. In-Vitro Diagnostics (Urine, Blood)
  6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  6.4.2. Market size analysis, by region, 2025–2035

Chapter 7. Global Legionella Testing Market Size & Forecasts by End User 2025–2035
7.1. Market Overview
7.2. Global Legionella Testing Market Performance – Potential Analysis (2025)
7.3. Hospitals
  7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  7.3.2. Market size analysis, by region, 2025–2035
7.4. Clinics
  7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  7.4.2. Market size analysis, by region, 2025–2035
7.5. Diagnostic Laboratories
  7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  7.5.2. Market size analysis, by region, 2025–2035
7.6. Water Treatment Industries
  7.6.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
  7.6.2. Market size analysis, by region, 2025–2035

Chapter 8. Global Legionella Testing Market Size & Forecasts by Region 2025–2035
8.1. Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America
  8.3.1. U.S.
    8.3.1.1. Test Type breakdown size & forecasts, 2025–2035
    8.3.1.2. Application breakdown size & forecasts, 2025–2035
  8.3.2. Canada
    8.3.2.1. Test Type breakdown size & forecasts, 2025–2035
    8.3.2.2. Application breakdown size & forecasts, 2025–2035
8.4. Europe
  8.4.1. UK
  8.4.2. Germany
  8.4.3. France
  8.4.4. Spain
  8.4.5. Italy
  8.4.6. Rest of Europe
  (Each with test type & application breakdowns)
8.5. Asia-Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Japan
  8.5.4. Australia
  8.5.5. South Korea
  8.5.6. Rest of APAC
  (Each with test type & application breakdowns)
8.6. Latin America
  8.6.1. Brazil
  8.6.2. Mexico
  8.6.3. Rest of LATAM
  (Each with test type & application breakdowns)
8.7. Middle East & Africa
  8.7.1. UAE
  8.7.2. Saudi Arabia
  8.7.3. South Africa
  8.7.4. Rest of MEA
  (Each with test type & application breakdowns)

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Abbott Laboratories – Company Profile
9.3. Bio-Rad Laboratories, Inc. – Company Profile
9.4. Thermo Fisher Scientific Inc. – Company Profile
9.5. Becton, Dickinson and Company – Company Profile
9.6. Qiagen N.V. – Company Profile
9.7. Eurofins Scientific SE – Company Profile
9.8. IDEXX Laboratories, Inc. – Company Profile
9.9. Danaher Corporation – Company Profile
9.10. Pall Corporation – Company Profile
9.11. LuminUltra Technologies Ltd. – Company Profile
9.12. Pro-Lab Diagnostics, Inc. – Company Profile
9.13. Aquacert Ltd. – Company Profile
9.14. ALS Limited – Company Profile
9.15. SUEZ Water Technologies & Solutions – Company Profile
9.16. Merck KGaA – Company Profile